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Abstract
Background: To study the molecular characteristics of a long-term, low frequency outbreak of blaKPC-2 in a low prevalence
setting involving the hospital environment.
Methodology/Principal Findings: KPC-producing bacteria were screened by selective chromogenic agar and Real-Time
PCR. The presence of antibiotic resistance genes was ascribed by PCRs and subsequent sequencing, and the KPC-producing
isolates were phylogenetically typed using PFGE and multi-locus sequence typing. BlaKPC-2-plasmids were identified and
analysed by S1-nuclease-PFGE hybridization and PCR based replicon typing. A ,97 kb IncFII plasmid was seen to carry
blaKPC-2 in all of the clinical isolates, in one of the isolates recovered from screened patients (1/136), and in the Klebsiella
pneumoniae and Enterobacter asburiae isolates recovered from the environment (sinks) in one intensive care unit. The K.
pneumoniae strain ST258 was identified in 6 out of 7 patients. An intergenus spread to E. asburiae and an interspecies
spread to two different K. pneumoniae clones (ST27 and ST461) of the blaKPC-2 plasmid was discovered. K. pneumoniae ST258
and genetically related E. asburiae strains were found in isolates of both human and environmental origins.
Conclusions/Significance: We document a clonal transmission of the K. pneumoniae ST258 strain, and an intergenus
plasmid diffusion of the IncFII plasmid carrying blaKPC-2 in this outbreak. A major reservoir in the patient population could
not be unveiled. However, the identification of a persisting environmental reservoir of strains with molecular determinants
linked to human isolates, suggests a possible role of the environment in the maintenance of this long-term outbreak.
Citation: Tofteland S, Naseer U, Lislevand JH, Sundsfjord A, Samuelsen Ø (2013) A Long-Term Low-Frequency Hospital Outbreak of KPC-Producing Klebsiella
pneumoniae Involving Intergenus Plasmid Diffusion and a Persisting Environmental Reservoir. PLoS ONE 8(3): e59015. doi:10.1371/journal.pone.0059015
Editor: Jan Kluytmans, Amphia Ziekenhuis, The Netherlands
Received November 26, 2012; Accepted February 8, 2013; Published March 11, 2013
Copyright:  2013 Tofteland et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
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Introduction
The Klebsiella pneumoniae carbapenemase (KPC) was first
identified in the USA in a Klebsiella pneumoniae isolate dated from
1996[1] and has subsequently been reported worldwide.[2] High
prevalence rates of KPC have been reported from regions and
countries such as USA, Israel, China, and Greece, while a number
of countries have reported hospital outbreaks and sporadic cases of
KPC-producing K. pneumonia. [2]
KPC has been identified in various species of Enterobacteria-
ceae and non-fermenters such as Pseudomonas aeruginosa and
Acinetobacter baumannii. [2] Further, blaKPC has been identified on
plasmids differing in size and structure. This broad species
distribution and plasmid diversity is likely due to the location of
blaKPC in a functional Tn3-based transposon structure (Tn4401)
with a high transposition frequency.[3] With respect to K.
pneumoniae, multilocus sequence typing (MLST) has shown that
the global dissemination of KPC-producing K. pneumoniae is
dominated by isolates belonging to a hyperepidemic clonal
complex including sequence type (ST) 258.[4] Although the
dissemination and outbreaks of KPC seems to be associated with
specific clones several reports are describing outbreaks where
several clones and different species are involved [5,6] as well as
individual patients containing different species harbouring
blaKPC.[7,8,9]
In many countries the emergence of KPC-producing bacteria
has been associated with import of isolates from high prevalent
areas. In Norway, the first case of K. pneumoniae with KPC was
associated with import from Greece in 2007 at a hospital in the
southern part of Norway.[10] Subsequently, five additional clinical
isolates were identified at the same hospital and a nearby hospital
from patients with no recent history of travel or hospitalisation
abroad. In this study we describe this long-term outbreak with
regards to the molecular characteristics of these isolates, plasmid
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content and dissemination, and the identification of KPC-
producing isolates in the hospital environment.
Materials and Methods
Hospital setting
Sørlandet Hospital (SH) is a 683-bed general hospital enterprise
located in three different cities in the southern part of Norway.
Due to sharing of some specialized medical functions a certain
degree of interchange of patients between the hospitals occurs.
Two hospitals belonging to Sørlandet Hospital, SH-Arendal (SH-
A), and SH-Kristiansand (SH-K), as well as a tertiary hospital
(Oslo University Hospital – Rikshospitalet (OUH-RH)) where
involved in this outbreak. A screening programme was imple-
mented during outbreak investigation involving a 12-bed (8 single
rooms and one 4-bed room) surgical/medical intensive care unit
(ICU-A) at SH-A.
Faecal and environmental screening programme
Faecal screening of ICU-A patients was initiated after the
identification of clinical case number 6 (K66-62). Prospective
screening was performed on patients (n = 50) on admittance and
discharge from the ICU-A during a first screening period from 8th
of May to 19th of October 2010, and then only on discharge from
the ICU-A during a second screening period from 19th of October
to 1st of April 2011 (n = 65). Retrospective screening was attempted
on 29 patients that had been hospitalized in the ICU-A at
overlapping intervals with patient 6. Seventeen of these were still
hospitalized and screened, whereas 4/12 discharged patients were
subjected to screening. Patients staying in the ICU-A for more
than 14 days were screened repeatedly every second week.
Screening of the environment was undertaken on two occasions,
from the 7th to the 9th of June 2010 and on the 27th of December
2010. The screenings involved sink drains in the ICU-A (n = 19),
the neighbouring post-operative unit, the coronary unit, and taps
for water to dialysis machines in the ICU-A. Environmental
samples were obtained with sterile, cotton-tipped swabs (COPAN
swabsH). Most areas examined were moist, but the cotton-tip was
occasionally moistened when the area examined appeared
relatively dry. Screening positive locations were disinfected and
then controlled by monthly screening.
Isolation of KPC-producing bacteria and detection of
blaKPC during the screening programme
Screening for KPC-producing bacteria was performed using
ChromID ESBL agar medium (bioMerieux, la Balme-les-Grottes,
France) and an enrichment medium (tryptic-soy broth containing
2 mg/L cefpodoxime). Real-Time PCR of blaKPC. was performed
directly on suspensions from the swab, enrichment medium, and
colonies from the ChromID ESBL agar[11].
Bacterial strains and clinical data
Clinical data and data on bacterial strains investigated in this
study are listed in Table 1 and 2.
Species identification
Bacterial identification was performed using the VITEK2 ID-
GNB system (bioMérieux, Marcy l’Etoile, France) and/or
MALDI-TOF (Microflex LT, Bruker Daltonics) with the MALDI
Biotyper 3.0 software version.
Antimicrobial susceptibility testing
Antimicrobial susceptibility of the isolates was determined using
Etest (bioMérieux) according to the manufacturer’s instruction.
The results were interpreted using breakpoints from the European
Committee for Antimicrobial Susceptibility Testing.[12]
Molecular characterisation of KPC-producing isolates
PCR and sequencing for blaKPC, blaTEM, blaSHV, blaCTX-M, and
a multiplex PCR for the most prevalent plasmid-borne blaAmpC -
genes was performed as previously described (Samuelsen JAC 09).
Isolates were typed by pulsed-field gel electrophoresis (PFGE) of
XbaI-digested total genomic DNA.[10] Strain relatedness was
analysed using BioNumerics version 6.0 (Applied Maths, Sint-
Martens-Latem, Belgium) using the band-based dice coefficient
and the unweighted pairs geometric-matched analysis dendrogram
with a position tolerance of 1% for optimization and band
comparison. Final comparison of bands for the interpretation of
relatedness was performed in accordance with Tenover crite-
ria.[13] Multi-locus sequence typing (MLST) was performed on K.
pneumoniae isolates according to the protocol described on the K.
pneumoniae MLST web site http://www.pasteur.fr/recherche/
genopole/PF8/mlst/Kpneumoniae.html.
Plasmid analysis
Plasmid profiling was performed using S1-nuclease digested
plasmid DNA, separated by PFGE.[10] Subsequently, plasmid
DNA was blotted onto nylon membrane and hybridised with
blaKPC specific probes to identify carrier plasmids. Furthermore,
plasmids were classified into incompatibility groups using the PCR
based replicon-typing (PBRT) scheme of Carattoli[14] and
hybridisation with replicon FII specific probes as previously
described.[10]
Transfer of resistance
Conjugal-transfer experiment was carried out in Luria-Bertani
broth at 37uC for clinical strain K47-25 as donor and rifampicin-
resistant E. coli J53-2 as recipient, mixed in a 1:9 ratio respectively.
Transconjugants were selected on LB-agar plates (Becton Dick-
inson, Sparks, MD) supplemented with 100 mg/L rifampicin
(Sigma-Aldrich, St. Louis, MO) and 2 mg/L ceftazidime (Sigma-
Aldrich).
Ethics statement
This study focuses on the molecular characteristics of bacterial
isolates collected as part of the clinical management and
microbiology routine work. Faecal screening was performed
according to the guidelines from the local hospital and collection
of clinical data as part of outbreak investigations for implemen-
tation of appropriate infection control measurements. Conse-
quently, ethical approval was not obtained for the study.
Results
Clinical cases
Six KPC-producing K. pneumoniae isolates from clinical samples
were recovered in SH from November 2007 to April 2010 (Table 1
and Table 2). The first two isolates had been characterised
previously.[10] The first patient had been hospitalized on Crete in
September 2007 prior to hospital admission in Norway. The other
patients had no history of recent travel abroad. 5 isolates were
recovered from SH-A, whereas the isolate from patient 2 was
recovered from SH-K. After the identification of KPC-producing
K. pneumoniae, measures for contact isolation were initiated for all
KPC Plasmid Diffusion and Environmental Reservoir
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patients. When patient 1 was readmitted at SH-K in March 2008
measurements for contact isolation was however not implemented.
Retrospective analysis of patient histories revealed that all SH-A
patients had been hospitalized in the same ICU (ICU-A) as the
index patient prior to detection of the KPC-producing isolates.
However, during their stay the patients had been admitted to 12
different wards. Further, conventional epidemiological evalua-
tion[15] was able to establish epidemiological links between
patient 1 and 2, and 3 and 4, while a possible link was suggested
between patient 4 and 5 (Table 2). Time and space overlaps
between the clinical cases 1 and 3 as well as 5 and 6 could not be
provided for, representing time intervals of 10 and 11 months,
respectively.
Several recognized risk factors for ESBL colonization and
infection[15,16,17,18] were present in all the patients that had
been admitted to the ICU-A prior to isolation of KPC-producing
K. pneumoniae (patient 1, 3–6) (Table 2). All patients were above 65
years of age. KPC-producing K. pneumoniae bacteraemia was
recognized in one patient, whereas the findings in the other
patients were regarded as most likely to be colonisations associated
with artificial ventilation or urinary catheter. One patient died, but
the KPC-producing K. pneumoniae was not considered to be
attributable to infection or death in this patient (Table 2).
ESBL-producing blaKPC-negative K. pneumoniae were also recov-
ered in ambulatory urinary samples due to urinary tract infections
(UTI) from three of the of the patients 26, 16, and 4 months after
the initial isolation of the KPC-producing K. pneumoniae isolates,
respectively (Table 1).
Patient screening
In the patient screening programme only 1/136 patients were
positive for KPC-producing Enterobacteriaceae (patient 7). Patient
7, being hospitalized in room 5 for his entire ICU-A stay, was
identified with KPC-producing K. pneumoniae (K66-73) and
Enterobacter asburiae (K66-74) upon discharge (Table 1), while
negative upon admission five days earlier. Room 5 was disinfected
using a persulfate based disinfectant after having been occupied by
patient 6 and then patient 7 was the first to be admitted two days
later.
Environmental screening
KPC-producing bacteria were detected in 4/19 environmental
locations in the ICU-A (sink drains in room 5, 6, 9, and the rinsing
room). BlaKPC-positive K. pneumoniae were identified in June 2010
from the sink drains in room 5 (K67-11 and K67-15) and room 6
(K67-13 and K63-14), and blaKPC-positive E. asburiae from the sink
drain in room 5 (K67-12 and K67-16) (Table 1). The sinks and
sink traps were decommissioned and the connecting pipe elbows
were disinfected using a chlorine disinfectant before new sinks and
sink traps were installed. Monthly environmental screening of
these positive locations was then undertaken. BlaKPC-positive K.
pneumoniae was again recovered from the sink in room 6 on two
occasions in December 2010 triggering a new environmental
screening in the ICU-A (data not shown). Additional sink drains in
the ICU-A was investigated, and two new locations that were not
subjected to investigation in June 2010 were now identified with
blaKPC-positive K. pneumoniae (room 9) and blaKPC-positive E.
asburiae (room 9 and the rinsing room, data not shown).
Although blaKPC-positive isolates have been identified in the
environment no additional clinical cases has been identified since
patient 6.














K47-25 P1 Nov 07 K. pneumoniae A2 258 KPC-2 SHV-11/-12 TEM-1 40, 97, 160 97,160
K48-58 P2 March 08 K. pneumoniae A2 258 KPC-2 SHV-11/-12 TEM-1 97, 242 97
K52-74 P3 Oct 08 K. pneumoniae A2 ND KPC-2 SHV-11/-12 TEM-1 40, 97, 194 97
K54-05 P4 Jan 09 K. pneumoniae A2 ND KPC-2 SHV-11 TEM-1 40, 97/100 97
K57-33 P5 March 09 K. pneumoniae B 461 KPC-2 SHV-1 TEM-1 48, 97, 225 97
K66-62 P6 April 10 K. pneumoniae A1 ND KPC-2 SHV-11/-12 TEM-1 40, 97, 194 97
K66-73 P7/F May 10 K. pneumoniae A1 258 KPC-2 SHV-11/-12 TEM-1 40, 97, 194 97
K66-74 P7/F May 10 E. asburiae C1 - KPC-2 NEG TEM-1 97,145 97
K67-04 P1 Jan 10 K. pneumoniae A1 258 NEG SHV-11/-12 NEG 40, 194 NEG
K67-05 P4 May 09 K. pneumoniae A2 258 NEG SHV-11/-12 NEG 40, 194 NEG
K67-06 P3 March 10 K. pneumoniae A2 258 NEG SHV-11/-12 NEG 40, 194 NEG
K67-11 E5 June 10 K. pneumoniae A2 ND KPC-2 SHV-11/-12 TEM-1 40, 97, 194 97
K67-12 E5 June 10 E. asburiae C2 - KPC-2 NEG TEM-1 97,145 97
K67-13 E6 June 10 K. pneumoniae D 27 KPC-2 NEG TEM-1 45, 97, 200 97
K67-14 E6 June 10 K. pneumoniae D 27 KPC NEG TEM-1 45, 97, 200 97
K67-15 E5 June 10 K. pneumoniae A1 ND KPC SHV-11/-12 TEM-1 40, 97, 194 97
K67-16 E5 June 10 E. asburiae C2 - KPC NEG TEM-1 97,145 97
1)P1–6 = clinical specimen from patients 1–6, P7/F = fecal screen patient 7, E = specimen from environmental screen (rooms 5, 6).
2)blaCTX-M was negative in all isolates. blapAmpC was negative in isolates from patients 1–6, others ND.
3)Plasmid profiling (S1-nuclease digested DNA (kB)).
4)Plasmid DNA hybridization with blaKPC specific probes.
doi:10.1371/journal.pone.0059015.t001
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Molecular characterisation of the isolates
PFGE and MLST typing revealed that 14 K. pneumoniae isolates
from both patients and the environment, including the three
blaKPC-negative K. pneumoniae UTI-isolates, belonged to two
clonally related pulsotypes (A1 and A2), that by MLST were
typed to ST258 (Figure 1, Table 1). Distinct K. pneumoniae PFGE/
MLST-types were recovered in patient 5 (K57-33; pulsotype B/
ST461) and isolates from the sink drain in room 6 (K67-13 and
K67-14; pulsotype D/ST27). PFGE of the E. asburiae isolates
revealed two closely related pulsotypes corresponding to the E.
asburiae (pulsotype C1) isolate from the screening patient (patient 7;
K66-47) and the two E. asburiae (pulsotype C2) isolate from room 5
(K67-12 and K67-16). The blaKPC-gene was sequenced in all
isolates from patients and from the environmental in June 2010
and found to be blaKPC-2 (Table 1). The blaKPC-positive K.
pneumoniae ST258 isolates harboured blaSHV-11, blaSHV-12, and
blaTEM-1, whereas the three blaKPC-negative K. pneumoniae ST258
UTI-isolates, harboured blaSHV-12 and blaSHV-11, but were
negative for blaTEM. The distinct K. pneumoniae STs in patient 5
(K57-33) and from room 6 (K67-13 and K67-14) harboured
blaSHV-1 and lacked the blaSHV-gene, respectively. The blaKPC-
positive E. asburiae isolates were devoid of blaSHV but harboured
blaTEM-1 (Table 1). PCRs for blaCTX-M and the most prevalent
plasmid-borne blaAmpC genes were negative.
Plasmid analysis
S1-nuclease-PFGE profiles revealed the presence 2-3 plasmids
in all isolates ranging from,40–,240 kb (Table 1, Figure 2).
Hybridization with blaKPC-specific probes identified a blaKPC-
carrier plasmid to approximately 97 kb in all blaKPC-positive
isolates of K. pneumoniae and E. asburiae. In the blaKPC-positive K.
pneumoniae isolate from patient 1 (K47-25) an additional blaKPC-
plasmid of ,160 kb was identified. PBRT and hybridization
characterized the ,97 kb plasmid as an IncFII replicon plasmid.
Except for the 97 kb blaKPC-plasmid, separate plasmid profiles
were recognized in the other K. pneumoniae pulsotypes/STs and the
closely related E. asburiae clones. The plasmid profile among the E.
asburiae isolates were identical (Table 1, Figure 2).
Interestingly, the plasmid profile of the pulsotype A/ST258
blaKPC-negative K. pneumoniae clinical UTI isolates was devoid of
the ,97 kb blaKPC-plasmid, indicating loss of this plasmid
(Table 1).
Transferability of blaKPC resistance
In vitro plasmid-transfer experiments using K47-25 as the donor
strain to E. coli resulted in transconjugants with a frequency of
2.561027 per donor cells.
Antimicrobial susceptibility
The antimicrobial susceptibility profile of the isolates is shown in
Table 3. Variable levels of reduced susceptibility to carbapenems
were observed in all the blaKPC-positive isolates whereas the three
ESBL-positive blaKPC-negative K. pneumoniae ST258 UTI isolates
were susceptible to carbapenems (Table 1). A similar susceptibility
profile with high-level resistance to penicillins and cephalosporins,
resistance to ciprofloxacin, tobramycin, and amikacin, but
susceptibility to gentamicin, were common to all K. pneumoniae
ST258/pulsotype A isolates. In contrast, the other blaKPC-positive
K. pneumoniae pulsotypes were susceptible to ciprofloxacin, tobra-
mycin, amikacin, and the gentamicin MIC was lower. The blaKPC-
positive E. asburiae isolates found in the screening positive patient
(patient 7) and the environment showed resistance to ciproflox-
acin, but were susceptible to the aminoglycosides.
All blaKPC-positive K. pneumoniae ST258 isolates were resistant to
colistin. 2 of 3 blaKPC-negative K. pneumoniae UTI isolates were
susceptible to colistin, whereas one isolate was resistant (K67-05)
displaying a clearly visible double zone (MIC 0.5 mg/L and MIC
16 mg/L).
Discussion
The dissemination of multidrug resistance plasmids among
Gram-negative bacteria is one of the major factors contributing to
Figure 1. Dendrogram of XbaI-digested genomic DNA. Strains of KPC-producing K. pneumoniae- and E.asburiae-isolates and ESBLA-producing
K. pneumonia are shown with percentages of similarity to the right of the dendrogram.
doi:10.1371/journal.pone.0059015.g001
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the spread of antimicrobial resistance.[19] However, information
about plasmid-dissemination during outbreaks is relatively limited.
Often the focus is restricted to specific bacterial species and the
dissemination of plasmids into different species might be
overlooked. Highly mobile plasmids resulting in ‘plasmid-borne
outbreaks’ may delay the recognition of an outbreak, and adds an
additional layer of complexity to the molecular investigation of
such outbreaks.[20] Plasmids have previously been linked to
outbreaks of multi-drug resistant (MDR) Gram-negative bacte-
ria[21,22,23,24,25], including nosocomial outbreaks of blaKPC-
containing plasmids in some studies.[5,7,8,20,26,27,28,29] Here
we describe the dissemination of a KPC-plasmid between strains
and species during a small long-term nosocomial outbreak in a
low-prevalence setting as well as the possible role of the
environment in this context. To the best of our knowledge this is
the first nosocomial outbreak report of KPC-producing bacteria
from the Nordic countries.
In vivo mobility is indicated by identification of the ,97 kb
IncFII blaKPC-2-plasmid in four distinct MLST/PFGE types of K.
pneumoniae and E. asburiae. This observation was supported by
successful in vitro conjugation of blaKPC-plasmids. blaKPC –
containing Tn4401 has been documented on plasmids of different
sizes belonging to different incompatibility
groups.[30,31,32,33,34] While mostly being reported on broad
host IncN plasmids[31], blaKPC has recently been reported on
narrow host range IncFII plasmids as well, promoting efficient
spread within members of Enterobacteriaceae.[33,35,36]
It is well known that plasmid-transfer can occur in vivo, but less is
known about plasmid-transfer occurring in the hospital environ-
ment. We can only speculate were the plasmid-transfer has
occurred in this setting. The first clinical cases were associated with
the hyperepidemic K. pneumoniae ST258 strain before plasmid-
dissemination were observed into other K. pneumoniae STs (ST27
and ST461) and E. asburiae, all of them devoid of non-b-lactam
resistances except the latter displaying low-level ciprofloxacin
resistance. The KPC-producing E. asburiae remained clinically
silent throughout the outbreak and first appeared in faecal
screening of patient 7. Faecal screening was not performed on
any of the clinical patients, thus whether KPC-producing E.
asburiae was carried by any of these patients remains elusive. The
finding of a distinct K. pneumoniae (ST27) with the ,97 kb KPC-
plasmid in the hospital environment but not in patients could
either be due to the unrecognized presence in patients and in vivo
plasmid-transfer or that the plasmid-transfer have occurred in the
environment before acquisition by a patient.
Interestingly, loss of blaKPC-plasmids, ,160 kb plasmid in
patient 1 and the ,97 kb plasmid in the three blaKPC-negative
K. pneumoniae UTI isolates, was observed in K. pneumoniae ST258
indicating either a high fitness cost or reduced plasmid stability.
Experiments to determine the fitness cost related to the ,97 kb
plasmid and its stability are ongoing.
Reservoirs in the patient or health care worker populations and
the environment represent principle modes of spread in nosoco-
mial outbreaks with the patient population being the most
important reservoir in high-frequent outbreaks.[37] Introduction
of the K. pneumoniae ST258 clone has caused major outbreaks in
many hospitals.[38] It is possible that a high level of adherence to
standard precautions prevented the establishment of a major
gastrointestinal reservoir in our patients, and thus, the prerequisite
of a major high-frequent outbreak, were not present.[37,39,40,41]
The lack of a patient reservoir and the persistence of the outbreak
despite the long interval between known clinical cases could
indicate other possible reservoirs contributing to occasional
transmissions and maintenance of the outbreak. Health care
workers were not screened for faecal or hand carriage partly as no
individuals with additional risk factors including dermatitis[37]
could be identified and partly due to the fact that the current
Norwegian health authority guidelines advocates against screening
of health care workers in nosocomial outbreaks of multidrug
resistant Gram-negative bacteria.[42] KPC-producing bacteria
were detected in as much as 21% of environmental locations in
screening samples from sink drains in the ICU-A. Moist surfaces
and especially sink drains have been focused in several studies as a
possible environmental source of transmission of Enterobacteria-
ceae, especially Klebsiella spp, to patients.[43,44,45,46,47,48]
Although the environment were decontaminated and sinks were
Figure 2. PFGE of S1 nuclease-digested total DNA. Lanes 1 and 20, phage l DNA ladder (concatemers of 48.5 kb); lane 2, K47-25; lane 3, K48-
58; lane 4, K52-74; lane 5, K54-05; lane 6, K57-33; lane 7, K66-62; lane 8, K66-73; lane 9, K66-74; lane 10, K67-04; lane 11, K67-05; lane 12, K67-06; lane
13, K67-11; lane 14, K67-12; lane 15, K67-13; lane 16, K67-14; lane 17, K67-15; lane 18, K67-16; lane 19, K. pneumoniae blaKPC -negative control strain.
doi:10.1371/journal.pone.0059015.g002
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replaced, KPC-producing E. asburiae and K. pneumoniae were
recovered during further environmental screening, suggesting that
these strains can survive well in that environment. Contamination
of the hands of health care workers due to occasional backsplash
during hand washing in a contaminated sink and sink
drains[44,46,47,49] or through moist surfaces near sinks and
faucets[45] has been suggested as a possible mode of transmission
to health care workers and subsequently to patients in the ICU
setting, facilitating low-frequent transmissions. The epidemiolog-
ical link between patient 6 and 7 through their succeeding use of
room 5 and the isolation of pulsotype identical KPC-producing K.
pneumoniae ST258 from both patients and the sink drain in that
room as well as the recovery of closely related KPC-producing E.
asburiae from faecal screening in patient 7 and the sink drain could
suggest a possible environmental source of colonization of patient
7.
Investigation revealed that several sinks were heavily contam-
inated by bacteria presumably from waste water washed down the
sink after cleaning of patients. A ‘bed bath’-system for cleaning of
patients were implemented to shortcut this opportunity. Repetitive
disinfection with a biofilm active disinfectant was considered, but
disinfection was only performed on two occasions; in June 2010
and January 2011.
In conclusion; the outbreak involved clonal spread of the
hyperepidemic K. pneumoniae ST258 stain as well as interspecies
plasmid transmission of a ,97 kb blaKPC-plasmid into two other
distinct K. pneumoniae strains and intergenus spread to E. asburiae.
The establishment of a local environmental reservoir was
documented. The spread among patients has probably occurred
partly as a result of transmission between patients in some of the
clinical cases, but we infer the possibility that the outbreak was
maintained and prolonged with additional clinical cases added due
to spread from environmental sources.
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